NCT04282512 (ROX_TENSIO18) is a NA clinical trial of Sodium bicarbonate-rich mineral water in Blood Pressure, sponsored by My Goodlife SAS.

Who is sponsoring NCT04282512?

NCT04282512 is sponsored by My Goodlife SAS.

What drugs are being tested in NCT04282512?

Interventions in NCT04282512: Sodium bicarbonate-rich mineral water.

What condition does NCT04282512 study?

NCT04282512 studies Blood Pressure.

Is NCT04282512 still recruiting?

NCT04282512 is currently completed. Last updated 24 February 2020.

Last reviewed 2020-02-24 · How we verify

NCT04282512: ROX_TENSIO18

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Effect of Sodium Bicarbonate Water on Blood Pressure in Normotensive Subjects

Completed NA Last updated 24 February 2020

What this trial tests

NA trial testing Sodium bicarbonate-rich mineral water in Blood Pressure in 100 participants. Completed in 20 December 2019.

Timeline

28 June 2019

Primary endpoint
15 November 2019

20 December 2019

Quick facts

Lead sponsor	My Goodlife SAS
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	100
Start date	28 June 2019
Primary completion	15 November 2019
Estimated completion	20 December 2019
Sites	1 location across France

Drugs / interventions tested

Sodium bicarbonate-rich mineral water

Conditions studied

Blood Pressure — all drugs for Blood Pressure →

Sponsor

My Goodlife SAS

Who can join

Adults 18 to 65, any sex, with Blood Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

ROX\_TENSIO18 is a randomised cross-over trial and the main objective is to evaluate the effect of daily consumption of sodium bicarbonate water for 15 days on blood pressure. Secondary objective are: * Evaluation of the effect of daily consumption of sodium bicarbonate water on total salt intake * Evaluation on blood pressure of the usual food groups that are the strongest contributors of salt intake.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blood Pressure

Currently open trials in the same condition.

NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04282512 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by My Goodlife SAS
Last refreshed: 24 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04282512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing